152 related articles for article (PubMed ID: 10975586)
1. Systemic, pulmonary, and renal hemodynamic effects of endothelin ET(A/B)-receptor blockade in patients with maintained left ventricular function.
Fleisch M; Sütsch G; Yan XW; Wenzel RR; Binggeli C; Bianchetti MG; Meier B; Kiowski W; Lüscher TF
J Cardiovasc Pharmacol; 2000 Sep; 36(3):302-9. PubMed ID: 10975586
[TBL] [Abstract][Full Text] [Related]
2. Acute endothelin A receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failure.
Givertz MM; Colucci WS; LeJemtel TH; Gottlieb SS; Hare JM; Slawsky MT; Leier CV; Loh E; Nicklas JM; Lewis BE
Circulation; 2000 Jun; 101(25):2922-7. PubMed ID: 10869264
[TBL] [Abstract][Full Text] [Related]
3. Haemodynamic and renal effects of endothelin receptor antagonism in patients with chronic kidney disease.
Dhaun N; Ferro CJ; Davenport AP; Haynes WG; Goddard J; Webb DJ
Nephrol Dial Transplant; 2007 Nov; 22(11):3228-34. PubMed ID: 17556408
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic and neurohumoral effects of selective endothelin A (ET(A)) receptor blockade in chronic heart failure: the Heart Failure ET(A) Receptor Blockade Trial (HEAT).
Lüscher TF; Enseleit F; Pacher R; Mitrovic V; Schulze MR; Willenbrock R; Dietz R; Rousson V; Hürlimann D; Philipp S; Notter T; Noll G; Ruschitzka F;
Circulation; 2002 Nov; 106(21):2666-72. PubMed ID: 12438291
[TBL] [Abstract][Full Text] [Related]
5. Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: comparison of effects with those of endothelin A receptor antagonism.
Wada A; Tsutamoto T; Ohnishi M; Sawaki M; Fukai D; Maeda Y; Kinoshita M
Circulation; 1999 Feb; 99(4):570-7. PubMed ID: 9927406
[TBL] [Abstract][Full Text] [Related]
6. Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure.
Kos T; Pacher R; Wimmer A; Bojic A; Hülsmann M; Frey B; Mayer G; Yilmaz N; Skvarilova L; Spinar J; Vitovec J; Toman J; Woloszcuk W; Stanek B
Wien Klin Wochenschr; 1998 Feb; 110(3):89-95. PubMed ID: 9553203
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients with class III to IV congestive heart failure.
Torre-Amione G; Young JB; Durand J; Bozkurt B; Mann DL; Kobrin I; Pratt CM
Circulation; 2001 Feb; 103(7):973-80. PubMed ID: 11181472
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular and renal actions of the endothelin(B) receptor in pigs.
Cirino M; Martin E; Yano M; Rodger IW
J Cardiovasc Pharmacol; 1997 Jun; 29(6):704-12. PubMed ID: 9234650
[TBL] [Abstract][Full Text] [Related]
9. Improvement of renal dysfunction in dogs with endotoxemia by a nonselective endothelin receptor antagonist.
Mitaka C; Hirata Y; Yokoyama K; Nagura T; Tsunoda Y; Amaha K
Crit Care Med; 1999 Jan; 27(1):146-53. PubMed ID: 9934909
[TBL] [Abstract][Full Text] [Related]
10. Renal haemodynamic effects of endothelin-1 and the ETA/ETB antagonist TAK-044 in anaesthetized rabbits.
Evans RG; Bergström G; Cotterill E; Anderson WP
J Hypertens; 1998 Dec; 16(12 Pt 2):1897-905. PubMed ID: 9886875
[TBL] [Abstract][Full Text] [Related]
11. Endothelin receptor blockade attenuates air embolization-induced pulmonary hypertension in sheep.
Miyahara T; Koizumi T; Kubo K; Hanaoka M; Kaneki T; Yamamoto H; Ge RL; Fujimoto K; Kobayashi T; Shibamoto T
Eur J Pharmacol; 1999 Dec; 385(2-3):163-9. PubMed ID: 10607872
[TBL] [Abstract][Full Text] [Related]
12. Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future?
Spieker LE; Noll G; Ruschitzka FT; Lüscher TF
J Am Coll Cardiol; 2001 May; 37(6):1493-505. PubMed ID: 11345356
[TBL] [Abstract][Full Text] [Related]
13. The increase in human plasma immunoreactive endothelin but not big endothelin-1 or its C-terminal fragment induced by systemic administration of the endothelin antagonist TAK-044.
Plumpton C; Ferro CJ; Haynes WG; Webb DJ; Davenport AP
Br J Pharmacol; 1996 Sep; 119(2):311-4. PubMed ID: 8886414
[TBL] [Abstract][Full Text] [Related]
14. Systemic blockade of the endothelin-B receptor increases peripheral vascular resistance in healthy men.
Strachan FE; Spratt JC; Wilkinson IB; Johnston NR; Gray GA; Webb DJ
Hypertension; 1999 Jan; 33(1 Pt 2):581-5. PubMed ID: 9931169
[TBL] [Abstract][Full Text] [Related]
15. Effects of long-term treatment with nonselective endothelin receptor antagonist, TAK-044, on remodeling of cardiovascular system with sustained volume overload.
Tojo T; Tsunoda Y; Nakada S; Tomoike H
J Cardiovasc Pharmacol; 2000 May; 35(5):777-85. PubMed ID: 10813381
[TBL] [Abstract][Full Text] [Related]
16. Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure.
Sütsch G; Kiowski W; Yan XW; Hunziker P; Christen S; Strobel W; Kim JH; Rickenbacher P; Bertel O
Circulation; 1998 Nov; 98(21):2262-8. PubMed ID: 9826312
[TBL] [Abstract][Full Text] [Related]
17. Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men.
Spratt JC; Goddard J; Patel N; Strachan FE; Rankin AJ; Webb DJ
Br J Pharmacol; 2001 Oct; 134(3):648-54. PubMed ID: 11588120
[TBL] [Abstract][Full Text] [Related]
18. Renal and systemic effects of chronic blockade of ET(A) or ET(B) receptors in normal rats and animals with experimental heart failure.
Francis B; Winaver J; Karram T; Hoffman A; Abassi Z
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S54-8. PubMed ID: 15838359
[TBL] [Abstract][Full Text] [Related]
19. Chronic therapy with an ET(A/B) receptor antagonist in conscious dogs during progression of congestive heart failure. Intracellular Ca(2+) regulation and nitric oxide mediated coronary relaxation.
Shen YT; Buie PS; Lynch JJ; Krause SM; Ma XL
Cardiovasc Res; 2000 Nov; 48(2):332-45. PubMed ID: 11054479
[TBL] [Abstract][Full Text] [Related]
20. Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans.
Haynes WG; Ferro CJ; O'Kane KP; Somerville D; Lomax CC; Webb DJ
Circulation; 1996 May; 93(10):1860-70. PubMed ID: 8635265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
